medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2009, Número 3

<< Anterior Siguiente >>

Acta Med 2009; 7 (3)


Diagnóstico diferencial del temblor

Ojeda LMC, Rodríguez WF, Amaya SLE

Idioma: Español
Referencias bibliográficas: 44
Paginas: 143-149
Archivo PDF: 75.22 Kb.


RESUMEN

El temblor es una oscilación rítmica e involuntaria que puede afectar uno o varios segmentos del cuerpo y es el movimiento anormal más común. Para su diagnóstico diferencial es esencial una historia y una evaluación clínica detalladas, identificando la distribución topográfica del temblor, sus condiciones de activación, amplitud y frecuencia. Sus causas son heterogéneas e identificarlas es fundamental para el tratamiento. Este artículo describe los síndromes de temblor más comunes y su tratamiento, así como varias estrategias para su diferenciación clínica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998; 13(suppl 3): 2-23.

  2. Zesiewicz TA, Hauser RA. Phenomenology and treatment of tremor disorders. Neurol Clin 2001; 19: 651-680, vii.

  3. Bhidayasiri R. Differential diagnosis of common tremor syndromes. Postgrad Med J 2005; 81: 756-762.

  4. Deuschl G, Krack P, Lauk M, Timmer J. Clinical neurophysiology of tremor. J Clin Neurophysiol 1996; 13: 110-121.

  5. Milanov I. Electromyographic differentiation of tremors. Clin Neurophysiol 2001; 112(9): 1626-1632.

  6. Elble RJ. Diagnostic criteria for essential tremor and differential diagnosis. Neurology 2000; 54(11): S2-S6.

  7. Charles PD, Esper GJ, Davis TL. Classification of tremor and update on treatment. Am Fam Physician 1999; 59: 1565-1572.

  8. Rehman H. Diagnosis and Management of tremor. Arch Intern Med 2000; 160: 2438-2444.

  9. Smaga S. Tremor. Am Fam Physician 2003; 68(8): 1545-1552.

  10. Jankovic J, Vuong KD, Thomas M. Psychogenic tremor: long-term outcome. CNS Spectr 2006; 11: 501-508.

  11. McAuley JH, Rothwell JC, Marsden CD, Findley LJ. Electrophysiological aids in distinguishing organic from psychogenic tremor. Neurology 1998; 50: 1882-1884.

  12. Hinson VK, Haren WB. Psychogenic movement disorders Lancet Neurol 2006; 5: 695-700.

  13. Deuschl G, Raethjen J, Lindemann M, Krack P. The pathophysiology of tremor. Muscle Nerve 2001; 24: 716-735.

  14. Reich SG. Psychogenic movement disorders. Semin Neurol 2006; 26: 289-296.

  15. Kenney C, Diamond A, Mejía N, Davidson A, Hunter C, Jankovic J. Distinguishing psychogenic and essential tremor. J Neurol Sci 2007; 263(1-2): 94-99.

  16. Deuschl G, Koster B, Lucking CH et al. Diagnostic and pathophysiological aspects of psychogenic tremors. Mov Disord 1998; 13: 294-302.

  17. Louis ED, Honig LS, Vonsattel JP, Maraganore DM, Borden S, Moskowitz CB. Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol 2005; 62: 1004-1007.

  18. Thanvi B, Lo N, Robinson T. Essential tremor-the most common movement disorder in older people. Age Ageing 2006; 35(4): 344-349.

  19. Lou JS, Jankovic J. Essential tremor: Clinical correlates in 350 patients. Neurology 1991; 41: 234-238.

  20. Higgins JJ, Pho LT, Nee LE. A gene (ETM) for essential tremor maps to chromosome 2p22–p25. Mov Disord 1997; 12: 859-864.

  21. Koller WC, Busenbark K, Gray C et al. Classification of essential tremor. Clin Neuropharmacol 1992; 15: 81-87.

  22. Gulcher JR, Jonsson P, Kong A et al. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet 1997; 17: 84-87.

  23. Louis ED, Zheng W, Jurewicz EC, Watner D, Chen J, Factor-Litvak P, Parides M. Elevation of blood b-carboline alkaloids in essential tremor. Neurology 2002; 59: 1940-1944.

  24. Louis ED, Pellegrino KM, Factor-Litvak P, Ríos E, Jiang W, Henchcliffe C, Zheng W. Cancer and blood concentrations of the comutagen harmane in essential tremor. Mov Disord 2008; 23(12): 1747-1751.

  25. Stratton SE, Lorden JF. Effect of harmaline on cells of the inferior olive in the absence of tremor: differential response of genetically dystonic and harmaline-tolerant rats. Neuroscience 1991; 41: 543-549.

  26. Benito-León J, Louis ED. Clinical update: Diagnosis and treatment of essential tremor. The Lancet 2007; 369: 1152-1154.

  27. Koller WC, Huber SJ. Tremor disorders of aging: Diagnosis and management. Geriatrics 1989; 44: 33-37.

  28. Koller WC, Vetere-Overfield B, Barter R. Tremors in early Parkinson’s disease. Clin Neuropharmacol 1989; 12(4): 293-297.

  29. Duval C. Rest and postural tremors in patients with Parkinson’s disease. Brain Res Bull 2006; 70(1): 44-48.

  30. Sawle G. Parkinson’s disease. Medicine 2004; 32(11): 93-96.

  31. Biagio MN, Bernardi G. The ‘magic’ of l-dopa: why is it the gold standard Parkinson’s disease therapy? Trends Pharmacol Sci 2005; 26(7): 341-344.

  32. Cutson TM, Laub KC, Schenkman M. Pharmacological and nonpharmacological interventions in the treatment of Parkinson’s disease. Phys Ther 1995; 75: 363-373.

  33. Bonuccelli U, Ceravolo R, Salvetti S, D’Avino C, Del Dotto P, Rossi G et al. Clozapine in Parkinson’s disease tremor. Effects of acute and chronic administration. Neurology 1997; 49(6): 1587-1590.

  34. Friedman JH, Koller WC, Lannon MC, Busenbark K, Swanson-Hyland E, Smith D. Benztropine versus clozapine for the treatment of tremor in Parkinson’s disease. Neurology 1997; 48(4): 1077-1081.

  35. Brown P, Rothwell JC, Stevens JM et al. Cerebellar axial postural tremor. Mov Disord 1997; 12: 977-984.

  36. Koller WC. Pharmacologic trials in the treatment of cerebellar tremor. Arch Neurol 1984; 41(3): 280-281.

  37. Sechi G, Agnetti V, Sulas FM, Sau GF, Corda D, Pitzouli MG, Rosati G. Effects of topiramate in patients with cerebellar tremor. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27(6): 1023-1027.

  38. Rice GP, Lesaux J, Vandervoort P, Macewan L, Ebers GC. Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor. J Neurol Neurosurg Psychiatry 1997; 62(3): 282-284.

  39. Gregory R. Surgery for movement disorders. J Neurol Neurosurg Psychiatry 2002; 72 Suppl 1: I32-I35.

  40. Kim MC, Son BC, Miyagi Y, Kang JK. Vim thalamotomy for Holmes’ tremor secondary to midbrain tumour. J Neurol Neurosurg Psychiatry. 2002; 73(4): 453-455.

  41. Hopfensberger KJ, Busenbark K, Koller WC. Midbrain tremor. En: Findley LJ, Koller WC. Handbook of tremor disorders. USA 1995: 445-459.

  42. Deuschl G, Krack P. Tremors: Differential diagnosis, neurophysiology and pharmacology. En: Jankovic J, Tolosa E. Parkinson’s disease and movement disorders. 3th ed. USA: Williams & Wilkins, 1998: 419-452.

  43. Gerschlager W, Munchau A, Katzenschlager P et al. Natural history and syndromic associations of orthostatic tremor: A review of 41 patients. Mov Disord 2004; 19: 788-795.

  44. Deuschl G. Tremor. Neurophysiol Lab 2008; 30: 49-57.




2020     |     www.medigraphic.com